Holdings (26)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.76780861% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 7.07682837% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 6.83825632% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 5.21448495% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 4.67718699% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 4.36913787% |
| Onesource Specialty Pharma Ltd. | Healthcare | Equity | 4.16951897% |
| Neuland Laboratories Ltd. | Healthcare | Equity | 3.97066636% |
| Piramal Pharma Ltd. | Healthcare | Equity | 3.94256901% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 3.39543699% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 6.05% | 22.46% | 11.96% | NA% |
| Category Average | -2.14% | 22.11% | 14.61% | NA% |
| Rank Within Category | 16.00% | 9.00% | 10.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 1.13%
Inclusive of GST
Exit load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Asthana is a M.A (Economics) from Mumbai University and PGDM (Investment Management) from NMIMS.
Experience
Prior to joining LIC MF, he has worked with UTI Mutual Fund, Tamohara Investment Managers, Axis Mutual Fund, Barclays Wealth Management, SBI Mutaul Fund, Quantum Mutual Fund and BRICS Securities Ltd.